Black Diamond Financial
CAPR icon

Black Diamond Financial’s Capricor Therapeutics CAPR Stock Holding History

Black Diamond Financial’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$749K Hold
79,077
– – 0.06% 91
2026
Q2 		$1.9M Hold
79,077
– – 0.17% 61
2026
Q1 		$2.4M Hold
79,077
– – 0.26% 51
2025
Q4 		$2.28M Sell
79,077
-198,660
-72% -$2.59M 0.24% 56
2025
Q3 		$2M Hold
277,737
– – 0.22% 57
2025
Q2 		$2.76M Hold
277,737
– – 0.43% 42
2025
Q1 		$2.64M Hold
277,737
– – 0.4% 42
2024
Q4 		$3.83M Buy
+277,737
New +$4.87M 0.57% 42

Other funds holding CAPR

Oppenheimer & Co
Oppenheimer & Co New York $9.5B AUM 27.65% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return
VestGen Advisors
VestGen Advisors Inverness, Illinois $3.25B AUM 30.95% 1-Year Est. Return
NBC Securities
NBC Securities Birmingham, Alabama $1.47B AUM 20.38% 1-Year Est. Return
STRS Ohio
STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return
Activest Wealth Management
Activest Wealth Management Aventure, Florida $540M AUM 34.92% 1-Year Est. Return
GoalVest Advisory
GoalVest Advisory New York $578M AUM 17.41% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

Black Diamond Financial's CAPR Position: Q3 2026 in Review

Black Diamond Financial held its Capricor Therapeutics (CAPR) position steady in Q3 2026 at 79,077 shares worth $749K. The position accounts for 0.06% of the portfolio, ranked #91.

Black Diamond Financial first reported a position in CAPR in Q4 2024 and has held it in 8 quarters since. The position peaked at $3.83M in Q4 2024. 25 funds tracked by Wall St. Rank hold CAPR as of Q3 2026.

  • Black Diamond Financial held 79,077 shares of Capricor Therapeutics worth $749K as of Q3 2026.
  • Black Diamond Financial left its Capricor Therapeutics share count unchanged in Q3 2026.
  • Capricor Therapeutics made up 0.06% of Black Diamond Financial's portfolio in Q3 2026, its #91 holding.
  • Black Diamond Financial first reported a position in Capricor Therapeutics in Q4 2024 and has held it in 8 quarters since.
  • Black Diamond Financial's Capricor Therapeutics position peaked at $3.83M in Q4 2024.
  • 25 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q3 2026.

Based on Black Diamond Financial's 13F filing for Q3 2026, filed 26 Oct 2026.